![Dose Fractionation of Moxifloxacin for Treatment of Tuberculosis: Impact of Dosing Interval and Elimination Half-Life on Microbial Kill and Resistance Suppression | Antimicrobial Agents and Chemotherapy Dose Fractionation of Moxifloxacin for Treatment of Tuberculosis: Impact of Dosing Interval and Elimination Half-Life on Microbial Kill and Resistance Suppression | Antimicrobial Agents and Chemotherapy](https://journals.asm.org/cms/10.1128/AAC.02533-20/asset/40c58080-4c51-4942-8073-93771f5fbff4/assets/images/large/aac.02533-20-f0001.jpg)
Dose Fractionation of Moxifloxacin for Treatment of Tuberculosis: Impact of Dosing Interval and Elimination Half-Life on Microbial Kill and Resistance Suppression | Antimicrobial Agents and Chemotherapy
![PDF] Moxifloxacin versus ethambutol in the first 2 months of treatment for pulmonary tuberculosis. | Semantic Scholar PDF] Moxifloxacin versus ethambutol in the first 2 months of treatment for pulmonary tuberculosis. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/1568e3bbc9fffd030cf8ac91db5c8f22b6545731/2-Table1-1.png)
PDF] Moxifloxacin versus ethambutol in the first 2 months of treatment for pulmonary tuberculosis. | Semantic Scholar
![Selection of a moxifloxacin dose that suppresses drug resistance in Mycobacterium tuberculosis, by use of an in vitro pharmacodynamic infection model and mathematical modeling. | Semantic Scholar Selection of a moxifloxacin dose that suppresses drug resistance in Mycobacterium tuberculosis, by use of an in vitro pharmacodynamic infection model and mathematical modeling. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/abfbf5cc440c5d20b8714b3e39c96a074a20deb6/6-Table1-1.png)